Joseph Horrigan has been appointed chief medical officer, AMO Pharma Ltd.   Dr. Horrigan has more than two decades of experience in the pharmaceutical industry and as a pediatric neuropsychiatrist. Dr. Horrigan has held multiple leadership positions in pharmaceuticals and medical research. Most recently he led clinical development programs in neurodevelopmental disorders at Neuren Pharmaceuticals, and he also co-founded and led the company-wide Medicines for Children Advisory Network at GlaxoS...